ArticleJournal of hematology & oncology2026

Luspatercept and imetelstat for myelodysplastic syndrome: updates from ASH 2025 annual meeting.

Yagya Ahlawat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.